CollPlant Biotechnologies...

NASDAQ: CLGN · Real-Time Price · USD
2.50
-0.11 (-4.21%)
At close: Aug 15, 2025, 3:57 PM
2.56
2.40%
After-hours: Aug 15, 2025, 06:26 PM EDT

CollPlant Biotechnologies Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
11.91M 26.67M 29.65M 13.15M
Short-Term Investments
n/a n/a n/a 30.15M
Long-Term Investments
n/a n/a 188K 213K
Other Long-Term Assets
118K 57K 188K 213K
Receivables
583K 393K 9K 270K
Inventory
440K 714K 1.43M 1.08M
Other Current Assets
248K 241K 566K 437K
Total Current Assets
13.18M 28.02M 31.66M 45.09M
Property-Plant & Equipment
5.28M 5.86M 5.68M 5.68M
Goodwill & Intangibles
131K 188K 245K 243K
Total Long-Term Assets
5.53M 6.1M 6.11M 6.14M
Total Assets
18.71M 34.13M 37.77M 51.22M
Account Payables
870K 980K 1.13M 1.03M
Deferred Revenue
n/a n/a n/a 32K
Short-Term Debt
n/a n/a 529K 519K
Other Current Liabilities
1.19M 1.54M -30K 47K
Total Current Liabilities
2.97M 3.25M 3.1M 3.01M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
2.27M 2.54M 2.38M 3.09M
Total Liabilities
5.25M 5.79M 5.49M 6.1M
Total Debt
3.08M 3.16M 2.91M 3.61M
Common Stock
4.98M 4.98M 4.87M 4.66M
Retained Earnings
-113.35M -96.74M -89.72M -72.8M
Comprehensive Income
-969K -969K -969K -969K
Shareholders Equity
13.46M 28.34M 32.28M 45.12M
Total Investments
n/a 57K 188K 30.15M